Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Drug Use You must have used at least one of the following semaglutide or GLP-1 receptor agonist drugs: Ozempic (semaglutide, Novo Nordisk) injectable, approved for Type 2 diabetes Wegovy (semaglutide, Novo Nordisk) injectable, approved for chronic weight management Rybelsus (semaglutide, Novo Nordisk) oral tablet form For vision loss (NAION) claims only, eligibility may also extend to: Mounjaro (tirzepatide, Eli Lilly) Zepbound (tirzepatide, Eli Lilly) Note: Trulicity (dulaglutide) and Saxenda/Victoza (liraglutide) are also GLP-1 drugs but involve different manufacturers and different litigation tracks
Other Safety Considerations A comprehensive review of post-marketing safety data identified that both drugs have been associated with gastrointestinal issues (nausea, vomiting, pancreatitis, diarrhea) as well as potential effects on bone remodeling, kidney function, and thyroid health
doi:10.1073/pnas.0813409106, PMID: 19223582 Vali S, Mythri RB, Jagatha B, Padiadpu J, Ramanujan KS, Andersen JK, Gorin F, Bharath MM (2007) Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinsons disease: a dynamic model
Does Semaglutide Hurt When Injected
While theres no direct interaction that increases side effects, the overlapping effects on blood pressure and fluid balance mean you should be monitored more carefully
US$ 23.42
US$ 21.78
US$ 27.59
US$ 27.93
US$ 28.62
US$ 24.86
